Geert Nygaard has joined Glycorex Transplantation AB (publ.) as Chief Executive Officer
As previously announced, Geert Nygaard has joined Glycorex Transplantation AB (publ.) as its CEO as per 15[th] December 2021. Geert brings over 30 years of experience in the diagnostics and life science markets from a variety of senior leadership roles with Abbott Laboratories, TECAN, Epigenomics and DAKO. “I am very excited to join the Glycorex Transplantation team as we are entering the next phase of expansion”, said Geert Nygaard. “We are focusing on increasing the global market reach for our existing Glycosorb ABO product and launching new exciting products for Universal Blood